NRC: National Research Corporation Stock

SIC 8731 – Commercial Physical and Biological Research

Valuation
Market Cap ($M) 834.79
Enterprise Value ($M) 864.82
Book Value ($M) 48.95
Book Value / Share 2.05
Price / Book 17.05
NCAV ($M) -49.12
NCAV / Share -2.06
Price / NCAV -16.99

Profitability (mra)
Return on Invested Capital (ROIC) 0.35
Return on Assets (ROA) 0.23
Return on Equity (ROE) 0.41

Liquidity (mrq)
Quick Ratio 0.67
Current Ratio 0.67

Balance Sheet (mrq) ($M)
Current Assets 24.36
Assets 122.44
Liabilities 73.48
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 148.58
Operating Income 40.05
Net Income 30.97
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 38.11
Cash from Investing -15.78
Cash from Financing -40.71

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-08 13G/A Kayne Anderson Rudnick Investment Management Llc 13.38 10.75
03-05 13D/A Common Property Trust 16.20
01-04 13D/A Amandla MK Trust 19.40 -10.89

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 8,248 55,554 14.85
2024-05-02 9,040 18,544 48.75
2024-05-01 7,321 15,609 46.90
2024-04-30 7,505 22,667 33.11
2024-04-29 6,440 19,617 32.83

(click for more detail)

Similar Companies
ABSI – Absci Corporation ICLR – ICON Public Limited Company
INCY – Incyte Corporation MEDP – Medpace Holdings, Inc.
MXCT – MaxCyte, Inc.


Financial data and stock pages provided by
Fintel.io